Nu Skin Enterprises Receivables

The latest receivables for NUS is $45M as of March 2026. That compares with $57M in the prior-year period — down 20.4% year over year. Investors often review this figure alongside Nu Skin Enterprises's historical trend and sector peers before judging valuation or financial health.

Over the past year, NUS's receivables moved from $57M to $45M — a 20.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nu Skin Enterprises's operating scale or balance-sheet position.

A receivables figure of $45M for NUS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NUS's receivables ($45M), review year-over-year change from $57M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Nu Skin Enterprises's receivables against similar Consumer Discretionary names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Discretionary companies and their key multiples and fundamentals.